Skip to main content
Premium Trial:

Request an Annual Quote

UC Irvine Lands $5.6M from NIH for Bioinformatics Training

NEW YORK (GenomeWeb News) - The Institute for Genomics and Bioinformatics at the University of California, Irvine, has won a five-year, $5.6 million award from the National Institute of Health's National Library of Medicine to fund educational programs in biomedical computing, the university said Thursday.
The Biomedical Informatics Training program trains graduate students and postdoctoral fellows at UC Irvine's School of Information and Computer Sciences.
UC Irvine said the program will provide specialized training for the students, who each will work with two faculty members from different disciplines and will team with students from another field as well.
The IGB programs will offer training in molecular biology and biochemistry, as well as computer modeling of biological systems, statistics, programming, and database development.
"We can use computers to better understand living systems and conversely draw inspiration from living systems to design better machines for processing information," said IGB director Pierre Baldi, who will oversee the training program.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.